Depression in patients with chronic obstructive pulmonary disease

Postgraduate Medicine

Volumn 124, Issue 3, 2012, Pages 101-109

  Garvey, Christine ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Chronic obstructive pulmonary disease; Depression; Diagnosis; Guidelines; Treatment

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; MAPROTILINE; MIANSERIN; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VILOXAZINE;

ALGORITHM; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DRUG WITHDRAWAL; DSM-IV; HEALTH CARE PERSONNEL; HUMAN; MORTALITY; PATIENT CARE; PRACTICE GUIDELINE; PROGNOSIS; PULMONARY REHABILITATION; QUESTIONNAIRE; UNITED STATES; UNSPECIFIED SIDE EFFECT; PSYCHOLOGICAL ASPECT; REVIEW;

ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; DEPRESSION; HUMANS; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES;

EID: 84867883926     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2012.05.2553     Document Type: Article

References (44)

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ. 2002;51(6):1-16.
2. World Health Organization. Chronic obstructive pulmonary disease (COPD): Fact sheet no. 315. Geneva: World Health Organization. http://www.who.int/mediacentre/factsheets/fs315/en/index.html. Last updated February 2011. Accessed July 6, 2011.
3. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.org. Updated December 2011. Accessed March 16, 2012.
4. Di Marco F, Verga M, Reggente M, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100(10):1767-1774.
5. Putman-Casdorph H, McCrone S. Chronic obstructive pulmonary disease, anxiety, and depression: state of the science. Heart Lung. 2009;38(1):34-47.
6. Schane RE, Walter LC, Dinno A, Covinsky KE, Woodruff PG. Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med. 2008;23(11): 1757-1762.
7. Ahmed K, Kelshiker A, Jenner C. The screening and treatment of undiagnosed depression in patients with chronic obstructive pulmonary disease (COPD) in a general practice. Prim Care Respir J. 2007;16(4):249-251.
8. Zhang MW, Ho RC, Cheung MW, Fu E, Mak A. Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry. 2011;33(3):217-223.
9. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167(1):60-67.
10. Dalal AA, Shah M, Lunacsek O, Hanania NA. Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. COPD. 2011;8(4):293-299.
11. Norwood R. Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med. 2006;12(2):113-117.
12. Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205-1211.
13. Xu W, Collet JP, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med. 2008;178(9):913-920.
14. de Voogd JN, Wempe JB, Koëter GH, et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest. 2009;135(3):619-625.
15. DiMatteo MR, Lepper HS, Croghan TW Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101-2107.
16. Lacasse Y, Rousseau L, Maltais F. Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2001;21(2):80-86.
17. Laurin C, Lavoie KL, Bacon SL, et al. Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest. 2007;132(1):148-155.
18. Coultas DB, Edwards DW, Barnett B, Wludyka P. Predictors of depressive symptoms in patients with COPD and health impact. COPD. 2007;4(1):23-28.
19. Cleland JA, Lee AJ, Hall S. Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Fam Pract. 2007;24(3):217-223.
20. Hanania NA, Mullerova H, Locantore NW, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011;183(5):604-611.
21. Quint JK, Baghai-Ravary R, Donaldson GC, Wedzicha JA. Relationship between depression and exacerbations in COPD. Eur Respir J. 2008;32(1):53-60.
22. Forest Pharmaceuticals Inc. Daliresp prescribing information. US Food and Drug Administration. http://www.accessdata.fda.gov/drug-satfdadocs/label/2011/022522s000 lbl.pdf Updated February 24, 2011. Accessed March 16, 2012.
23. Pfizer Inc. Chantix prescribing information. US Food and Drug Administration. http://www.accessdata.fda.gov/drugsatfda_docs/ label/2012/021928s028 lbl.pdf. Updated January 20, 2012. Accessed March 16, 2012.
24. Norwood R, Balkissoon R. Current perspectives on management of co-morbid depression in COPD. COPD. 2005;2(1):185-193.
25. Maurer J, Rebbapragada V, Borson S, et al; ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4 suppl):43S-56S.
26. van Eijk JT, Diederiks JP, Kempen GI, Honig A, van der Meer K, Brenninkmeijer WJ. Development and feasibility of a nurse administered strategy on depression in community-dwelling patients with a chronic physical disease. Patient Educ Couns. 2004;54(1):87-94.
27. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder, third edition. American Psychiatric Association. http://www.psychiatryonline.com/pracGuide/PracticePDFs/PG_Depression3rdEd.pdf. Updated October 2010. Accessed July 6, 2011.
28. Julian LJ, Gregorich SE, Earnest G, et al. Screening for depression in chronic obstructive pulmonary disease. COPD. 2009;6(6):452-458.
29. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA. 1994;272(22):1749-1756.
30. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
31. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737-1744.
32. Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminarayan S, VanTuinen C. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics. 1992;33(2):190-201.
33. Evans M, Hammond M, Wilson K, Lye M, Copeland J. Placebo-controlled treatment trial of depression in elderly physically ill patients. Int J Geriatr Psychiatry. 1997;12(8):817-824.
34. Lacasse Y, Beaudoin L, Rousseau L, Maltais F. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis. 2004;61(3): 140-147.
35. Eiser N, Harte R, Spiros K, Phillips C, Isaac MT Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD. 2005;2(2):233-241.
36. National Collaborating Centre for Mental Health. Depression in adults with a chronic physical health problem: treatment and management. National Institute for Health and Clinical Excellence. http://www.nice.org.uk/nicemedia/pdf/CG91FullGuideline.pdf. Accessed March 16, 2012.
37. Rayner L, Price A, Evans A, Valsraj K, Higginson IJ, Hotopf M. Antidepressants for depression in physically ill people. Cochrane Database Syst Rev. 2010;3:CD007503.
38. Mottram P, Wilson K, Strobl J. Antidepressants for depressed elderly. Cochrane Database Syst Rev. 2006;1:CD003491.
39. Bratås O, Espnes GA, Rannestad T, Walstad R. Pulmonary rehabilitation reduces depression and enhances health-related quality of life in COPD patients-especially in patients with mild or moderate disease. Chron Respir Dis. 2010;7(4):229-237.
40. Alexopoulos GS, Sirey JA, Raue PJ, Kanellopoulos D, Clark TE, Novitch RS. Outcomes of depressed patients undergoing inpatient pulmonary rehabilitation. Am J Geriatr Psychiatry. 2006;14(5): 466-475.
41. Hynninen MJ, Bjerke N, Pallesen S, Bakke PS, Nordhus IH. A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med. 2010;104(7):986-994.
42. Livermore N, Sharpe L, McKenzie D. Panic attacks and panic disorder in chronic obstructive pulmonary disease: a cognitive behavioral perspective. Respir Med. 2010;104(9):1246-1253.
43. Kraus CA, Kunik ME, Stanley MA. Use of cognitive behavioral therapy in late-life psychiatric disorders. Geriatrics. 2007;62(6):21-26.
44. Kendrick T, Dowrick C, McBride A, et al. Management of depression in UK general practice in relation to scores on depression severity questionnaires: analysis of medical record data. BMJ 2009; 338:B750.